Ipragliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, Ameliorates Nonalcoholic Fatty Liver Disease in Japanese Patients with Type 2 Diabetes Mellitus
Tashima, Kanako, Ogino, Jun, Yoneda-Karasawa, Chihiro, Nishino, Takayoshi, Hashimoto, Naotake
Published in Tokyo Women's Medical University Journal (20.12.2019)
Published in Tokyo Women's Medical University Journal (20.12.2019)
Get full text
Journal Article
Association of morning fasting blood glucose variability with insulin antibodies and clinical factors in type 1 diabetes
Yoneda, Chihiro, Tashima-Horie, Kanako, Fukushima, Sayaka, Saito, Satoko, Tanaka, Sayoko, Haruki, Takenori, Ogino, Jun, Suzuki, Yoshifumi, Hashimoto, Naotake
Published in Endocrine Journal (2016)
Published in Endocrine Journal (2016)
Get full text
Journal Article
Ipragliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, Ameliorates Nonalcoholic Fatty Liver Disease in Japanese Patients with Type 2 Diabetes Mellitus
Tashima, Kanako, Ogino, Jun, Yoneda-Karasawa, Chihiro, Nishino, Takayoshi, Hashimoto, Naotake
Published in Tokyo Women's Medical University Journal (2019)
Published in Tokyo Women's Medical University Journal (2019)
Get full text
Journal Article